Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Nestlé To Reduce Added Sugars in Chocolate, Without Compromising Taste

XTALKS VITALS NEWS

Chocolate

According to Nestlé, maker of Kit Kats and Aeros, their scientists have developed a way to restructure the sugar molecules, allowing them to dissolve more quickly to give an equivalent level of sweetness to the products.

Share this!

December 5, 2016 | by Sarah Hand, M.Sc.

Swiss food company, Nestlé, has discovered a method of removing up to 40 percent of the added sugar in some of its chocolate bars, without changing the taste. According to Nestlé, maker of Kit Kats and Aeros, their scientists have developed a way to restructure the sugar molecules, allowing them to dissolve more quickly to give an equivalent level of sweetness to the products.

This novel form of sugar could be added sparingly to chocolate products, thereby reducing the amount of sugar necessary to deliver the same taste. Nestlé has plans to patent the sugar restructuring process, and use it to reformulate some of its chocolate confectionary products.

“This truly groundbreaking research is inspired by nature and has the potential to reduce total sugar by up to 40% in our confectionery,” said Nestlé’s chief technology officer, Stefan Catsicas. “Our scientists have discovered a completely new way to use a traditional, natural ingredient.”

Sugar has been implicated in the increasing problem of obesity in developed nations around the world. In 2014, a group of specialists came together to form Action on Sugar, a group aimed at convincing manufacturers to reduce sugar in all foods by 30 percent.



Nestlé’s research on the fast-dissolving sugar should help it stay competitive in the confectionary market, where consumers are increasingly looking to lower sugar options. The company plans to begin adding the new form of sweetener to its products in 2018.

Currently, a standard four-finger Kit Kat contains 23.8 grams of sugar. If this was cut by 40 percent using the new sugar, the amount would be reduced to 14.3 grams.

According to UK-based nutritionists, people over the age of 11 years old should consume no more than 30 grams of sugar per day. This amount equates to 5 percent of total calories consumed. Around 15 percent of the total calorific intake for children ages 11 to 18 currently consists of sugar.


Keywords: Food Industry,Added Sugar, Obesity


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Researchers Identify Role of ApoE4 Gene as Possible Drug Target in Alzheimer’s Disease

September 21, 2017 - A team of neurology researchers at Washington University School of Medicine in St. Louis have found that in the presence of the ApoE4 protein, another protein known as tau forms tangles in the brain which contributes to neuronal damage characteristic of Alzheimer’s disease.

Featured In: Life Science News


New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths

September 20, 2017 - Clinicians at The University of Texas MD Anderson Cancer Center have published new guidelines in the journal, Nature Reviews Clinical Oncology, which could help in the management of these toxicities.

Featured In: Biotech News, Drug Safety News


Microneedle Skin Patch Could Treat Common Metabolic Disorders

September 19, 2017 - Researchers at Columbia University Medical Center (CUMC) and the University of North Carolina have developed a microneedle skin patch impregnated with a drug capable of converting white fat into calorie-burning brown fat.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Development and Manufacture of Highly Potent API Drug Products Throughout the Clinical Phases


Innovation through Integration – Providing Next Generation Biomedical Devices and Interconnects


Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance


Why Phase 3 Trials Fail: Oncology Case Studies and Lessons Learned


Copyright © 2016-2017 Honeycomb Worldwide Inc.